Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rugina Ali"'
Autor:
Michael Barker, Rugina Ali
Publikováno v:
EMJ Rheumatology. :33-40
In a highly interactive symposium, a multidisciplinary faculty from across Europe assembled to discuss how best to meet the expectations of patients with rheumatoid arthritis (RA) in an increasingly complex therapeutic landscape. The introduction of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7665ab6eaba479bf57b5472be11d3c5
https://doi.org/10.33590/emjrheumatol/10311043
https://doi.org/10.33590/emjrheumatol/10311043
Autor:
Michael Barker, Rugina Ali
Publikováno v:
EMJ Gastroenterology. :10-17
The emergence of anti-TNF biosimilars has had significant implications for the biologic treatment of inflammatory bowel disease (IBD). Significant cost savings provide an incentive for healthcare providers to encourage the prescription of biosimilars
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c79379badd3eadc6f4bfcbad4cdb3116
https://doi.org/10.33590/emj/10310701
https://doi.org/10.33590/emj/10310701
Autor:
Laura Bella, Rugina Ali
Publikováno v:
EMJ Rheumatology. :36-43
With an increasing number of biosimilars receiving regulatory approval, the treatment landscape for rheumatic diseases is evolving. Healthcare professionals (HCP) are being presented with an expanding armamentarium of treatment options that can incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb05326710248ed80b996884e9ffc66f
https://doi.org/10.33590/emjrheumatol/10312502
https://doi.org/10.33590/emjrheumatol/10312502
Autor:
Rugina Ali, Phil Ford
Publikováno v:
EMJ Rheumatology. :42-48
Biosimilars have been available in Europe since 2006, and biosimilars of monoclonal antibodies since 2013, and are now a widespread clinical reality. Since their introduction, various sources of data have become available to help physicians make know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2272e2c536c97ef25df96234c8718e3d
https://doi.org/10.33590/emjrheumatol/10311526
https://doi.org/10.33590/emjrheumatol/10311526
Autor:
Rafael Luján, Andrea Volterra, Maria Amalia Di Castro, Iaroslav Savtchouk, Hiltrud Stubbe, Rugina Ali
Publikováno v:
RUIdeRA. Repositorio Institucional de la UCLM
instname
Proceedings of the National Academy of Sciences of the United States of America, vol. 116, no. 27, pp. 13602-13610
Proceedings of the National Academy of Sciences of the United States of America
instname
Proceedings of the National Academy of Sciences of the United States of America, vol. 116, no. 27, pp. 13602-13610
Proceedings of the National Academy of Sciences of the United States of America
Significance We previously identified a mechanism controlling transmitter release probability at perforant path (PP)–granule cell excitatory synapses, a memory-related circuit that goes awry in Alzheimer’s disease and temporal lobe epilepsy. We f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3f912b20eca9ff6ce2e8e25b70ef3ac
https://www.pnas.org/cgi/doi/10.1073/pnas.1816013116
https://www.pnas.org/cgi/doi/10.1073/pnas.1816013116
